Gilead Sciences, Inc. (GILD)
167.95
-1.78
(-1.05%)
USD |
NASDAQ |
Nov 12, 16:00
168.13
+0.18
(+0.11%)
After-Hours: 07:42
Gilead Sciences Shareholders Equity (Quarterly) : 13.04B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 13.04B |
| June 30, 2026 | 11.83B |
| March 31, 2026 | 23.52B |
| December 31, 2025 | 22.70B |
| September 30, 2025 | 21.54B |
| June 30, 2025 | 19.67B |
| March 31, 2025 | 19.16B |
| December 31, 2024 | 19.33B |
| September 30, 2024 | 18.48B |
| June 30, 2024 | 18.28B |
| March 31, 2024 | 17.54B |
| December 31, 2023 | 22.83B |
| September 30, 2023 | 22.31B |
| June 30, 2023 | 21.16B |
| March 31, 2023 | 21.00B |
| December 31, 2022 | 21.24B |
| September 30, 2022 | 21.08B |
| June 30, 2022 | 20.24B |
| March 31, 2022 | 19.93B |
| December 31, 2021 | 21.07B |
| September 30, 2021 | 21.47B |
| June 30, 2021 | 19.70B |
| March 31, 2021 | 18.95B |
| December 31, 2020 | 18.20B |
| September 30, 2020 | 17.44B |
| Date | Value |
|---|---|
| June 30, 2020 | 18.03B |
| March 31, 2020 | 22.07B |
| December 31, 2019 | 22.52B |
| September 30, 2019 | 20.60B |
| June 30, 2019 | 22.62B |
| March 31, 2019 | 21.95B |
| December 31, 2018 | 21.39B |
| September 30, 2018 | 22.86B |
| June 30, 2018 | 21.67B |
| March 31, 2018 | 20.59B |
| December 31, 2017 | 20.44B |
| September 30, 2017 | 24.84B |
| June 30, 2017 | 22.68B |
| March 31, 2017 | 20.44B |
| December 31, 2016 | 18.89B |
| September 30, 2016 | 16.87B |
| June 30, 2016 | 15.54B |
| March 31, 2016 | 13.40B |
| December 31, 2015 | 18.53B |
| September 30, 2015 | 17.41B |
| June 30, 2015 | 16.29B |
| March 31, 2015 | 17.18B |
| December 31, 2014 | 15.43B |
| September 30, 2014 | 13.57B |
| June 30, 2014 | 16.09B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 33.50B |
| AbbVie, Inc. | -4.583B |
| Biogen, Inc. | 18.92B |
| Vertex Pharmaceuticals, Inc. | 20.91B |
| Amgen, Inc. | 14.35B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.41B |
| Total Liabilities (Quarterly) | 38.45B |
| Debt to Equity Ratio | 2.012 |
| Current Ratio | 1.379 |
| Net Debt Paydown Yield | -0.14% |